on VALBIOTIS (EPA:ALVAL)
Half-year review of Valbiotis' liquidity contract
On January 19, 2026, Valbiotis, a French laboratory specializing in food supplements, released the data for the half-year balance sheet of its liquidity contract with Portzamparc. As of December 31, 2025, the liquidity account held 40,894 Valbiotis shares and €24,765.63.
In comparison, as of June 30, 2025, the account held 41,924 shares and €21,433.93. Over six months, 132,602 shares were purchased for a total of €99,305.03, while 133,632 shares were sold for €102,719.23. The half-year valuation highlights a slight decrease in the number of shares but an increase in the euro balance.
The liquidity contract complies with AMF decision no. 2018-01. Valbiotis informs of its obligations regarding capital threshold crossings from 5%.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all VALBIOTIS news